Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):531-9. doi: 10.1016/j.bpg.2010.07.014.
PMID:20955957
COVID-19 and liver injury: An ongoing challenge.
Papagiouvanni I, Kotoulas SC, Pataka A, Spyratos DG, Porpodis K, Boutou AK, Papagiouvannis G, Grigoriou I, Vettas C, Goulis I.
World J Gastroenterol. 2023 Jan 14;29(2):257-271. doi: 10.3748/wjg.v29.i2.257.
PMID:36687117
Nimesulide-induced acute hepatitis.
Sbeit W, Krivoy N, Shiller M, Farah R, Cohen HI, Struminger L, Reshef R.
Ann Pharmacother. 2001 Sep;35(9):1049-52. doi: 10.1177/106002800103500901.
PMID:11573855
Acetyl-L-carnitine for patients with hepatic encephalopathy.
Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, Martí-Amarista CE.
Cochrane Database Syst Rev. 2019 Jan 5;1(1):CD011451. doi: 10.1002/14651858.CD011451.pub2.
PMID:30610762
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C.
Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A.
Drugs. 2010 Jun 18;70(9):1131-48. doi: 10.2165/10898630-000000000-00000.
PMID:20518580
Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.
Alessandrino F, Tirumani SH, Krajewski KM, Shinagare AB, Jagannathan JP, Ramaiya NH, Di Salvo DN.
Clin Radiol. 2017 Jul;72(7):521-533. doi: 10.1016/j.crad.2017.04.003. Epub 2017 May 2.
PMID:28476244
[Expert consensus on the treatment of chronic kidney disease with tuberculosis (2022 version)].
Chinese Society for Tuberculosis, Chinese Medical Association.
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Oct 12;45(10):996-1008. doi: 10.3760/cma.j.cn112147-20220327-00241.
PMID:36207956
HIV-related liver disease: infections versus drugs.
Sidiq H, Ankoma-Sey V.
Gastroenterol Clin North Am. 2006 Jun;35(2):487-505. doi: 10.1016/j.gtc.2006.05.001.